CFDA Number
93.395
Unique assistance listing ID
CFDA 93.395 — federal assistance program administered by National Institutes of Health, sourced from the SAM.gov Assistance Listings catalog.
Administered by National Institutes of Health (NIH)
Program overview. CFDA 93.395 — Cancer Treatment Research — is a federal assistance listing in the Health category, administered by National Institutes of Health (NIH). The typical award range cataloged on SAM.gov is $200,000 to $5.0 million. The program is currently active in the SAM.gov Assistance Listings database. Eligible applicants include Educational Institution.
Funding opportunities. PlainGrants has indexed 20 Grants.gov opportunity announcements tied to CFDA 93.395. Of those, 2 are currently open for applications and 18 have closed. The next closing date is September 7, 2026. The largest award ceiling seen across these announcements is $1.6 million. Individual Notice of Funding Opportunity documents on Grants.gov carry the exact deadlines, required forms, and submission instructions.
Next steps. Before applying for CFDA 93.395, confirm your organization has an active SAM.gov registration and a Unique Entity ID (UEI) — these are mandatory for every federal funding instrument. Read the current Notice of Funding Opportunity end-to-end, paying close attention to the cost-share or matching requirement, the evaluation criteria, and the narrative page limits. Health-category grants routinely require Institutional Review Board (IRB) approval for any research involving human subjects and may require Single Project Assurance registration. For structural help, the guides linked below cover SAM.gov setup, NOFO interpretation, and common rejection reasons.
CFDA Number
93.395
Unique assistance listing ID
Category
Health
Federal grant subject area
Open Opportunities
2
Currently open for applications
$200,000 to $5.0 million
Typical Award Range
$200,000 to $5.0 million
Application Deadline
Annual
Category
Health
Clinical and laboratory research on cancer treatment including chemotherapy, immunotherapy, and surgery.
Ready to Apply?
Visit the official program website for current application requirements and deadlines.
National Institutes of Health
Biomedical and behavioral research grants for universities, institutions, and investigators.
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (CHD-MH) (U54 Clinical Trial Optional)
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
Showing 10 of 20 opportunities.
Adoption Assistance
Advanced Education Nursing Traineeships
Advanced Nursing Education Workforce
Alcohol Research Center Grants
Alcohol Research Programs
Disclaimer: This information is sourced from SAM.gov Assistance Listings (CFDA) and is for informational purposes only. Program requirements, deadlines, and availability change frequently. Always verify current requirements directly with the awarding agency before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology — how this data is sourced, computed, and verified.
| Publisher | Kiznis Studio |
| Sources | Public official public datasets |